Literature DB >> 8282674

Lack of cognitive impairment in first-degree relatives of children with pervasive developmental disorders.

P Szatmari1, M B Jones, L Tuff, G Bartolucci, S Fisman, W Mahoney.   

Abstract

OBJECTIVE: The objective of this study was to test the hypothesis that mild cognitive impairments aggregate in the unaffected first-degree relatives of probands with autism or pervasive developmental disorders (PDD).
METHOD: The unaffected siblings and parents of 52 PDD probands and 33 Down syndrome and low birth weight controls were administered a battery of psychometric tests. The tests included measures previously found to be depressed in siblings of autistic children as well as cognitive deficits seen in PDD subjects of normal IQ. In addition, the Vineland Adaptive Behavior Scales were administered to siblings to measure the social-communication impairments found in PDD.
RESULTS: Neither the siblings nor parents of the PDD probands demonstrated lower cognitive or adaptive behavior scores compared with controls. Developmental histories did not reveal greater rates of social, cognitive, or language delays, nor was there evidence to suggest that relatives of subgroups of PDD probands were different from each other.
CONCLUSION: These findings indicate that, apart from relatives with PDD, cognitive and social impairments do not aggregate in the families of PDD probands.

Entities:  

Mesh:

Year:  1993        PMID: 8282674     DOI: 10.1097/00004583-199311000-00022

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  28 in total

Review 1.  Heterogeneity and the genetics of autism.

Authors:  P Szatmari
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

2.  A family genetic study of autism associated with profound mental retardation.

Authors:  E Starr; S K Berument; A Pickles; M Tomlins; A Bailey; K Papanikolaou; M Rutter
Journal:  J Autism Dev Disord       Date:  2001-02

3.  Examination of potential overlap in autism and language loci on chromosomes 2, 7, and 13 in two independent samples ascertained for specific language impairment.

Authors:  Christopher W Bartlett; Judy F Flax; Mark W Logue; Brett J Smith; Veronica J Vieland; Paula Tallal; Linda M Brzustowicz
Journal:  Hum Hered       Date:  2004       Impact factor: 0.444

Review 4.  The screening and diagnosis of autistic spectrum disorders.

Authors:  P A Filipek; P J Accardo; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S Teplin; R F Tuchman; F R Volkmar
Journal:  J Autism Dev Disord       Date:  1999-12

5.  Cognitive and verbal abilities of 24- to 36-month-old siblings of children with autism.

Authors:  Nurit Yirmiya; Ifat Gamliel; Michal Shaked; Marian Sigman
Journal:  J Autism Dev Disord       Date:  2007-02

6.  Neuropsychological functioning of siblings of children with autism, siblings of children with developmental language delay, and siblings of children with mental retardation of unknown genetic etiology.

Authors:  Tammy Pilowsky; Nurit Yirmiya; Varda Gross-Tsur; Ruth S Shalev
Journal:  J Autism Dev Disord       Date:  2007-03

Review 7.  Nosological and genetic aspects of Asperger syndrome.

Authors:  F R Volkmar; A Klin; D Pauls
Journal:  J Autism Dev Disord       Date:  1998-10

Review 8.  Genetics of autism: overview and new directions.

Authors:  P Szatmari; M B Jones; L Zwaigenbaum; J E MacLean
Journal:  J Autism Dev Disord       Date:  1998-10

9.  Brief report: stability and change in cognitive and behavioral characteristics of autism through childhood.

Authors:  L C Eaves; H H Ho
Journal:  J Autism Dev Disord       Date:  1996-10

10.  Impairments in phonological processing and nonverbal intellectual function in parents of children with autism.

Authors:  Gwen L Schmidt; Lila K Kimel; Erin Winterrowd; Bruce F Pennington; Susan L Hepburn; Donald C Rojas
Journal:  J Clin Exp Neuropsychol       Date:  2008-07       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.